References
- ThöneJEllrichmannGOral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culpritsDrug Healthc Patient Saf20135374723459383
- BharatAXieFBaddleyJWIncidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseasesArthritis Care Res201264612615
References
- RahmlowMShusterEADominikJLeflunomide-associated progressive multifocal leukoencephalopathyArch Neurol200865111538153919001176
- BharatAXieFBaddleyJWIncidence and risk factors for progressive multifocal leukoencephalopathy among patients with selected rheumatic diseasesArthritis Care Res201264612615
- LuEWangBWGuimondCSafety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilanceExpert Rev Neurother20131325126023448215